INTEGRA LIFESCIENCES HOLDINGS CORP Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $3.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $3.24M, a 379.03% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $232.00K, a 75.78% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $5.64M, a 183.67% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $4.86M, a 222.36% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $12.14M, a 240.48% increase from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $3.56M, a 63.78% decline from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $9.84M, a 86.36% decline from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $72.17M, a 472.32% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $3.48M 10-Q · filed 2026-07-29 | $9.12M derived: sum of 3 quarters · filed 2026-07-29 | $13.98M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2026-03-31 | $232.00K 10-Q · filed 2026-05-05 | $5.88M derived: sum of 2 quarters · filed 2026-05-05 | $10.73M derived: sum of 3 quarters · filed 2026-05-05 | $11.41M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-12-31 | $5.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.50M derived: sum of 2 quarters · filed 2026-02-26 | $11.18M derived: sum of 3 quarters · filed 2026-07-29 | $12.14M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $4.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.54M derived: sum of 2 quarters · filed 2026-07-29 | $6.49M 10-Q · filed 2025-10-30 | $8.48M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-06-30 | $677.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.64M 10-Q · filed 2026-07-29 | $3.63M derived: sum of 3 quarters · filed 2026-07-29 | $5.13M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-03-31 | $958.00K 10-Q · filed 2026-05-05 | $2.95M derived: sum of 2 quarters · filed 2026-05-05 | $4.46M derived: sum of 3 quarters · filed 2026-05-05 | $3.78M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.50M derived: sum of 2 quarters · filed 2026-02-26 | $2.82M derived: sum of 3 quarters · filed 2026-02-26 | $3.56M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $829.00K derived: sum of 2 quarters · filed 2025-10-30 | $1.57M 10-Q · filed 2025-10-30 | -$8.12M derived: sum of 4 quarters · filed 2025-10-30 | |
| 2024-06-30 | -$678.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $68.00K 10-Q · filed 2025-07-31 | -$9.63M derived: sum of 3 quarters · filed 2025-07-31 | $2.33M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | $746.00K 10-Q · filed 2025-05-05 | -$8.95M derived: sum of 2 quarters · filed 2025-05-05 | $3.01M derived: sum of 3 quarters · filed 2025-05-05 | $8.87M derived: sum of 4 quarters · filed 2025-05-05 | |
| 2023-12-31 | -$9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.26M derived: sum of 2 quarters · filed 2025-02-25 | $8.12M derived: sum of 3 quarters · filed 2025-02-25 | $9.84M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $11.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $17.82M derived: sum of 2 quarters · filed 2024-11-04 | $19.54M 10-Q · filed 2024-11-04 | $16.12M derived: sum of 4 quarters · filed 2024-11-04 | |
| 2023-06-30 | $5.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $7.58M 10-Q · filed 2024-07-29 | $4.16M derived: sum of 3 quarters · filed 2024-07-29 | $15.26M derived: sum of 4 quarters · filed 2024-07-29 | |
| 2023-03-31 | $1.72M 10-Q · filed 2024-05-06 | -$1.70M derived: sum of 2 quarters · filed 2024-05-06 | $9.40M derived: sum of 3 quarters · filed 2024-05-06 | $73.38M derived: sum of 4 quarters · filed 2024-05-06 | |
| 2022-12-31 | -$3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $7.68M derived: sum of 2 quarters · filed 2024-02-28 | $71.66M derived: sum of 3 quarters · filed 2024-02-28 | $72.17M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $11.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $75.08M derived: sum of 2 quarters · filed 2023-10-25 | $75.59M 10-Q · filed 2023-10-25 | $77.47M derived: sum of 4 quarters · filed 2023-10-25 | |
| 2022-06-30 | $63.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $64.49M 10-Q · filed 2023-07-27 | $69.49M 10-Q · filed 2022-07-27 | $66.37M derived: sum of 3 quarters · filed 2023-07-27 | $66.57M derived: sum of 4 quarters · filed 2023-07-27 |
| 2022-03-31 | $507.00K 10-Q · filed 2023-04-26 | $2.39M derived: sum of 2 quarters · filed 2023-04-26 | $2.59M derived: sum of 3 quarters · filed 2023-04-26 | $3.46M derived: sum of 4 quarters · filed 2023-04-26 | |
| 2021-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $2.08M derived: sum of 2 quarters · filed 2023-02-22 | $2.95M derived: sum of 3 quarters · filed 2023-02-22 | $12.61M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $1.06M derived: sum of 2 quarters · filed 2022-10-26 | $10.72M 10-Q · filed 2022-10-26 | $10.74M derived: sum of 4 quarters · filed 2022-10-26 | |
| 2021-06-30 | $866.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $10.53M 10-Q · filed 2022-07-27 | $10.55M derived: sum of 3 quarters · filed 2022-07-27 | $10.55M derived: sum of 4 quarters · filed 2022-07-27 | |
| 2021-03-31 | $9.66M 10-Q · filed 2022-04-27 | $9.68M derived: sum of 2 quarters · filed 2022-04-27 | $9.68M derived: sum of 3 quarters · filed 2022-04-27 | $9.88M derived: sum of 4 quarters · filed 2022-04-27 | |
| 2020-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $20.00K derived: sum of 2 quarters · filed 2022-02-24 | $219.00K derived: sum of 3 quarters · filed 2022-02-24 | $6.03M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $199.00K derived: sum of 2 quarters · filed 2021-11-02 | $6.01M 10-Q · filed 2021-11-02 | $5.57M derived: sum of 4 quarters · filed 2021-11-02 | |
| 2020-06-30 | $199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $6.01M 10-Q · filed 2021-07-29 | $5.57M derived: sum of 3 quarters · filed 2021-07-29 | $9.78M derived: sum of 4 quarters · filed 2021-07-29 | |
| 2020-03-31 | $5.81M 10-Q · filed 2021-04-29 | $5.37M derived: sum of 2 quarters · filed 2021-04-29 | $9.59M derived: sum of 3 quarters · filed 2021-04-29 | $45.23M derived: sum of 4 quarters · filed 2021-04-29 | |
| 2019-12-31 | -$437.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $3.78M derived: sum of 2 quarters · filed 2021-02-23 | $39.42M derived: sum of 3 quarters · filed 2021-02-23 | $41.42M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $4.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $39.86M derived: sum of 2 quarters · filed 2019-10-25 | $41.86M 10-Q · filed 2019-10-25 | ||
| 2019-06-30 | $35.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $37.65M 10-Q · filed 2019-07-25 | |||
| 2019-03-31 | $2.00M 10-Q · filed 2019-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |